China Treasures New Materials (2439) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
15 Oct, 2026Executive summary
H1 revenue rose 8.6% YoY to RMB196.868m; profit for the period increased 24.9% to RMB48.208m, with higher gross profit and no listing expenses versus RMB2.3m in H1 2023.
Biodegradable products remained the core business; Dongguan Phase 1 operated at full scale, while Anji had yet to achieve stable production.
Financial highlights
Gross profit increased 10.4% to RMB78.4m and gross margin rose to 39.8% from 39.1%; cost of sales was RMB118.480m versus RMB110.339m.
Profit before tax was RMB56.469m versus RMB45.784m; attributable profit was RMB47.834m versus RMB38.175m.
Other income fell to RMB0.9m from RMB2.9m, including government grants of RMB0.4m versus RMB1.6m and interest income of RMB0.5m versus RMB1.3m.
Selling and distribution expenses decreased to RMB2.4m from RMB3.2m; administrative and other operating expenses declined to RMB18.7m from RMB20.2m, partly offset by higher R&D spending.
Net cash from operating activities was RMB61.2m versus RMB48.0m; cash and cash equivalents were RMB381.714m at 30 June 2024 versus RMB315.696m at 31 December 2023.
Outlook and guidance
PRC restrictions on non-degradable plastic use are expanding, with a stated policy objective to prohibit non-degradable bags in various marketplaces by end-2025.
Management sees favorable biodegradable-product prospects, citing policy-driven demand and increased takeaway consumption and home meal preparation; Dongguan expansion supports Southeast China growth.
Changchun expansion was delayed, though trial production had begun on new machinery; proceeds-use timelines for expansion and R&D funding extended to 2024.
Allocation of unutilized listing proceeds may be revised after review of FY2024 financial conditions, with an announcement where applicable.
Latest events from China Treasures New Materials
- Biodegradable demand lifted H1 revenue as cost inflation trimmed gross margin.2439
H1 2023 - Biodegradable product growth lifted FY2023 profit 48.5% as expansion advanced and margins eased.2439
H2 2023 - Profit rose 32.9% as biodegradable demand and Changchun consolidation shaped FY2024.2439
H2 2024 - Online-led demand weakness cut H1 profit as Changchun expansion lifted leverage.2439
H1 2025 - Revenue and profit contracted sharply as the new Changchun base neared operations.2439
H2 2025 - H1 profit fell 47.8% as weaker demand and new-base costs pressured margins.2439
H1 2026